Scarica l'app Stockscreener
2.49
0.80%
-0.02
Aerovate Therapeutics Inc Azioni (AVTE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
11.57%
24.62
|
22.07 | 21.37 | 20.34 | 17.64 |
| Operating Income/Loss |
11.57%
-24.62
|
-22.07 | -21.37 | -20.34 | -17.64 |
| Income/Loss From Continuing Operations Before Tax |
13.90%
-23.19
|
-20.36 | -19.56 | -19.02 | -16.52 |
| Income/Loss From Continuing Operations After Tax |
13.58%
-23.19
|
-20.41 | -19.56 | -19.02 | -16.52 |
|
Net Income/Loss
|
13.58%
-23.19
|
-20.41 | -19.56 | -19.02 | -16.52 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,949%
27.80
|
0.4595 | 27.64 | 25.17 | 24.78 |
| Diluted Average Shares |
5,949%
27.80
|
0.4595 | 27.64 | 25.17 | 24.78 |
| Basic Earnings Per Share |
12.16%
-0.83
|
-0.74 | -0.71 | -0.76 | -0.67 |
| Diluted Earnings Per Share |
12.16%
-0.83
|
-0.74 | -0.71 | -0.76 | -0.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):